B2B ad examples

Jetzt bewerben im #TeamGFO!

That's a wrap on #ESMO26 in Madrid! We're leaving inspired by the science, collaboration and shared commitment to improving outcomes for patients. From new data to meaningful discussions, thank you to everyone who connected with us and to ESMO - European Society for Medical Oncology for another exceptional congress. Take a look back at some of our highlights from Madrid! See you at #ESMO27! #AsOneForPatients #Oncology #RareTumors

Some tumors typically don't metastasize. That doesn't mean they don't change lives. Chronic pain. Lost mobility. Surgery after surgery. For people living with desmoid tumors, TGCT and NF1-PN, the burden is measured in whether they can move, work and live well. We're advancing science to change that.

Medical Unit RNs: Connect your assessment skills with coordinated patient care. Find your next opportunity at FroedtertJobs.com.

ED RNs: Bring your emergency nursing experience to Froedtert. Explore roles at FroedtertJobs.com.

Smarter analytics and expert review flag risk earlier, so plans prevent more payment errors.

Accurate provider data protects Medicaid program integrity. See why revalidation matters.

Bring your programs, roles and priorities. A personalized Welligent demo shows documentation, scheduling and billing working together.

Evaluating HCM and payroll for behavioral health? Request a personalized DATIS e3 demo focused on your workforce priorities.

HearUSA is proud to partner with Deaflympian, world-record-holding swimmer and reality TV star Matt Klotz. 💜 Having worn hearing aids since the age of two, Matt knows firsthand the role that better hearing can play in staying connected and pursuing what you love. Together, Matt and HearUSA are helping raise awareness around hearing loss, hearing health and the importance of finding hearing care that fits your life. #HearUSA #MattKlotz #HearingHealth #HearingLoss #HearingAids

Curious how reagent supply chain volatility is shaping the future of in vitro diagnostics? While antibodies scale reliably in conventional systems, complex diagnostic antigens and enzymes frequently face severe expression bottlenecks and lot-to-lot inconsistencies. Read our latest piece on building a resilient diagnostic supply chain 👇

Advancing innovative drug delivery through strategic collaboration. Gannet BioChem is pleased to announce a development and cGMP supply agreement with Re-Vana Therapeutics to support the advancement of its proprietary biodegradable polymer platforms for sustained-release drug delivery. By combining Re-Vana’s innovative ophthalmic technologies with Gannet’s expertise in polymer chemistry, process development, and cGMP manufacturing, this collaboration aims to support next-generation therapies designed to reduce treatment burden and improve patient outcomes. The agreement will support Re-Vana’s EyeLief® and OcuLief® platforms, as well as emerging non-ocular applications. We're excited to take this next step together! Read the full announcement: https://lnkd.in/ef4Pbmyg #GannetBioChem #ReVanaTherapeutics #DrugDelivery #Biotechnology #cGMP #Ophthalmology

A magyarok 81%-át nyomasztotta valami annyira az elmúlt évben, hogy kihatott a munkájára, alvására vagy kapcsolataira. Mit tehet ezzel a munkáltató? Ingyenes webinár november 5-én 13:00-kor.

Scaling self-service content takes more than technology. It takes a partnership that helps teams change how they work. Our new Almirall × Shaman case explores how co-creation, hands-on support and user adoption helped enable more agile content production and global-to-local reuse. For Shaman, partnership means working alongside teams to build reusable content structures, support adoption and turn new capabilities into everyday practice. Thank you to Almirall team for the trust and collaboration, and to Lucillia Abbud Marketing for sharing your experience and helping bring this story to life. Discover the approach and results: https://lnkd.in/dGybiPYg Ready to build your own content success story? Let’s explore how Shaman can partner with your team to make it happen. #ContentExcellence #PharmaMarketing #ContentReuse #GlobaltoLocal

Tervezed a 2027-es juttatásokat? Horovitz Biankával végigvesszük az Ipsos Hedepy megbízásából készült friss kutatásának magyar adatait, és azt, mit jelentenek a HR számára. Ingyenes webinár november 5-én 13:00-kor.

#𝐃𝐘𝐊 | 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐭𝐚𝐛𝐥𝐞𝐬 𝐚𝐧𝐝 𝐥𝐢𝐬𝐭𝐢𝐧𝐠𝐬 𝐝𝐨𝐧’𝐭 𝐚𝐥𝐰𝐚𝐲𝐬 𝐭𝐞𝐥𝐥 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐬𝐭𝐨𝐫𝐲 𝐛𝐞𝐡𝐢𝐧𝐝 𝐚𝐧 𝐞𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐬𝐢𝐠𝐧𝐚𝐥. As trial data evolves, IDMCs need to look beyond standard outputs to understand what may be driving a signal and focus on the evidence that matters most. Our latest resource explores how experienced #SDAC support—combining statistical expertise, data management, and effective reporting—can help turn complex interim data into clear, reliable information for independent review. 📊 𝐅𝐫𝐨𝐦 𝐂𝐨𝐦𝐩𝐥𝐞𝐱 𝐃𝐚𝐭𝐚 𝐭𝐨 𝐂𝐥𝐞𝐚𝐫𝐞𝐫 𝐈𝐧𝐬𝐢𝐠𝐡𝐭: 𝐒𝐃𝐀𝐂 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡𝐞𝐬 𝐭𝐨 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐈𝐧𝐝𝐞𝐩𝐞𝐧𝐝𝐞𝐧𝐭 𝐃𝐚𝐭𝐚 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 👉 Get your copy here: https://lnkd.in/eydTqvav #IDMC #Biostatistics #ClinicalTrials #ClinicalResearch

Learn what to look for beyond utilization metrics and how continuous care relationships can improve outcomes while reducing unnecessary spend.

Une chose est certaine : la performance d’un programme de chirurgie robot-assistée se construit bien au-delà de la technologie. Elle repose aussi sur la fiabilité des systèmes, l’accompagnement des équipes et l’optimisation continue des pratiques. Chez Intuitive, nous accompagnons les établissements afin de faciliter l’organisation et le bon déroulement de leur programme opératoire au quotidien. Grâce à l’analyse des données, à la maintenance préventive et à l’expertise de nos équipes, nous contribuons à renforcer la fiabilité des systèmes et à favoriser la continuité des activités au bloc opératoire, pour que les équipes soignantes puissent rester pleinement concentrées sur leurs patients. C’est aussi ce qui fait la force de notre écosystème : au-delà des systèmes chirurgicaux da Vinci au bloc opératoire, notre écosystème associe services, outils numériques et accompagnement pour soutenir les établissements dans la durée. Pour en savoir plus sur notre écosystème : https://lnkd.in/eXAwXzK4 #WeAreIntuitive

Reproducible 3D only pays off when the biology holds up across every team and site. See how pharma R&D groups are standardizing RASTRUM™ 3D cell models into screening-scale workflows, generating data worth scaling and candidate decisions they can stand behind.

Struggling to produce enough correctly folded, active protein for your herbicide tolerance trait studies? Discover how trait developers are overcoming recombinant expression, assembly, and purification bottlenecks across major commercial HT enzyme classes. 🌾 Read the full breakdown 👇

From model design to readout, RASTRUM™ builds reproducible 3D cell models into a repeatable screening workflow.

Explore nursing opportunities in beautiful British Columbia, Canada! ⛰️🍁 Join our US Internationally Educated Nurse (IEN) Virtual Information Session to connect with our recruitment team and learn more about our careers! 📅 November 17, 2026 🕛 10 a.m. - 11 a.m. PDT ✅ Explore Nursing Opportunities ✅ Discover Supports Available to IENs ✅ Meet Our Recruitment Team ✅ Learn About the Recruitment Process ✅ Have Your Questions Answered

Die Zukunft der Transplantation gestalten Herzliche Gratulation an Dr. Frederik Haupenthal, Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Gewinner des Young Investigator Award - Klinisch 2026 mit dem Beitrag «Torque Teno Virus-Guided vs. Standard Immunosuppression in Kidney Transplant Recipients: The TTVguideIT Randomised Controlled Trial», der im Rahmen des Austrotransplant-Kongresses verliehen wurde. Wissenschaftlicher Fortschritt in der Transplantationsmedizin lebt vom Engagement, der Neugier und den Ideen der nächsten Generation von Forschenden, Ärztinnen und Ärzten. Mit der langfristigen Unterstützung des Young Investigator Award engagiert sich Astellas für die Förderung der klinischen und translationalen Transplantationsforschung sowie junger Talente, die die Zukunft der Transplantationsmedizin aktiv mitgestalten. Wir gratulieren herzlich zu dieser verdienten Auszeichnung und danken der Austrotransplant-Community für ihren kontinuierlichen Einsatz für wissenschaftlichen Austausch und Exzellenz. Der Young Investigator Award wird von Astellas unterstützt. #Transplantation #ClinicalResearch #YoungInvestigatorAward #MedicalEducation MAT-AT-NON-2026-00043 | Date of preparation 08/2026

Shaping the Future of Transplantation Congratulations to Dr. Frederik Haupenthal, Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna. He is the winner of the Young Investigator Award 2026 – Clinical and was honoured at the Austrotransplant Congress for his presentation: "Torque Teno Virus-Guided vs. Standard Immunosuppression in Kidney Transplant Recipients: The TTVguideIT Randomised Controlled Trial." Scientific progress in transplantation depends on the curiosity, dedication and innovation of the next generation of researchers and clinicians. Through its longterm support of the Young Investigator Award, Astellas is proud to contribute to the advancement of clinical and translational transplantation research and to encourage young talents shaping the future of transplantation. Congratulations on this well-deserved recognition, and thank you to the Austrotransplant community for its continued commitment to scientific excellence and collaboration. The Young Investigator Award is supported by Astellas. #Transplantation #ClinicalResearch #YoungInvestigatorAward #MedicalEducation MAT-AT-NON-2026-00044 | Date of preparation 08/2026